Vaccine Development

Jul 08, 2016
By BioPharm International Editors
The company will collaborate with the Walter Reed Army Institute of Research to co-develop a Zika vaccine candidate.
Jun 28, 2016
By BioPharm International Editors
MilliporeSigma and the International Vaccine Institute in Seoul, South Korea aim to develop more robust, scalable vaccine manufacturing processes.
Jun 28, 2016
Antibodies to dengue may either confer protective immunity to the Zika virus or enhance disease severity in secondary, related infections such as Zika.
Jun 23, 2016
Studying broadly neutralizing antibodies in infants may lead to new pathways in HIV vaccine development.
Jun 16, 2016
A new indication for Emergent BioSolutions’ BioThrax will give the drug market exclusivity through November 2022.
Jun 09, 2016
The inactivated vaccine, manufactured with a GE FlexFactory system, could be associated with fewer adverse reactions than the live vaccine option.
May 10, 2016
By BioPharm International Editors
Phase I clinical trials of PfSPZ revealed it may protect healthy adults, who have not been exposed to Malaria before, for more than on year.
May 04, 2016
By BioPharm International Editors
MilliporeSigma expands its Carlsbad, California-based GMP capacity for viral and gene-therapy products by nearly 90%.
Apr 20, 2016
Traditional methods of measuring the effectiveness of vaccines against the flu are called into question by new findings from the NIH.
Apr 04, 2016
Even though the organizers of New York’s Tribeca Film Festival decided not to air the anti-vaccine film by discredited British researcher Andrew Wakefield, the so-called documentary is getting a healthy run and further perpetuating the myth of a link between childhood vaccination and autism.
native1_300x100
lorem ipsum